Institute Research Scientist
MD Anderson Cancer Center
With two decades of experience in drug discovery and clinical trial management across academia and pharmaceutical companies, my expertise lies in oncology and the drug discovery process - target validation, screening funnel assay development, lead optimization, pharmacological biomarkers studies, PK/PD relationships, patient stratification, and Phase I trials management. I am committed to advance novel therapeutics and new treatments to cancer patients.